Name: * Email: * Telephone: * Company: * Best time to call: * Message: Captcha:*     Leverage Innovation To Transform Drug Discovery & Development Productivity. Network with up to 150 leaders, create a competitive advantage and revolutionise your R&D Innovation at the 3rd Annual Global Discovery to Development Innovation Forum 2010. The Annual GDDIF is the leading R&D summit for industry leaders and strategists. It is the only two day gathering dedicated to both strategy and Innovation across the drug discovery & development realm. Read More PREVIOUS GBX SUMMITS SPEAKERS view all   Steve Street Vice President for Research. Head of Pfizer R&D Cont. Improvement Gross, Gerhard, Section Director ADME in AstraZeneca UK Dr Harsukh Parmar Global Head of Early Clinical Dev't, Resp. & Inflammation Therapy Astra Zenica Tony Wood Vice President, Head of Worldwide Medicinal Chemistry, Pfizer Global Research & Development

R&D Innovation & Strategies –Integrated Strategies To Over Come Pitfalls, Enhance Drug Discovery, Overcome Attrition & New Prediction Tools That Drive Clear Decision Making. Focused Sirna Screens In Disease Based Assays - The Fast Track To A Target Non-Invasive, Label-Free Assays - Getting the Most Out of your Targets and a Handle on Off-Target Effects In Silico Innovation To Solve Drug Discovery – In-Silico Data, Data Mining, Predictive Modeling, Exploring the impact & success rate of HTS Compound Library Screening. Partnerships, Alliances & Outsourcing –Successful Partnerships, Managing Alliances, Balancing Conflicting Interests, Biotech Technology Platforms Intergration of technologies & applications to bridge the gap between discovery, validation & development How do you create intelligence from all this data, both structured and unstructured, across the entire value chain? Streamline data processes and integration whilst improving early decision making and lowering attrition through the benefit of developing a dynamic workflows and an efficient infrastructure. “An innovative approach”-lean/ 6-sigma efforts and organisational structures supporting lead optimisation." Alternative cost effective screening methods and techniques to strengthen assay effectively. Bringing in-vitro screening for HTS, hit optimisation & lead optimisation together.   CONFIRMED 2010 ATTENDEES WE ONLY INVITE & ATTRACT THE MOST POWERFUL DELEGATES GLOBALLY:   Company Name Job Title Country (OSI) Pharmaceuticals Director Research Technologies UK (OSI) Pharmaceuticals Director PreClinical Safety & Dev Project Director UK Accelrys Senior Vice President, Marketing Services UK Accelrys CSO USA Accelrys Ltd Sales Director UK Aperio International Manager USA Astion Pharma A/S CEO Denmark Astra Zeneca Director New Opportunities UK Astra Zeneca VP R&D Lead New Opportunities UK Astra Zeneca Global Value Chain Leader for CV&GI Discovery UK Astra Zeneca VP New Opportunities, R&D UK Astra Zeneca Director UK Astrazeneca Global Head of Early Clinical Development UK AstraZeneca Associate Director USA AstraZeneca R&D, Principal Scientist in Global Clinical Development Sweden Biomarker Consortium NIH Program Director USA Biomax Informatics CEO Germany Biostatus Ltd Sales & Marketing Director UK Boehringer Ingeheim Head if IS R&D&M Germany Cancer Research UK Director of Translational Research UK Cisbio Head of Technology and Chemistry France Cisbio Bioassays Head Of Marketing France CTL MD USA Discoverx Director, EMEA UK Eggcentris CEO Germany ERA 7 CEO Spain Evotec (UK) Ltd Executive Vice President Business UK F. Hoffmann-La Roche Pharma Development Quality Assurance Switzerland Fraunhofer Institute Director of Toxicology and Experimental Medicine  Germany Frost  Senior Analysis, Drug Discovery USA Galapagos NV Senior vice president drug Discovery UK Galapagos NV Director for Quality and Safety UK GlaxoSmithKline  Chemistry Leader UK GLPG Senior Director for Quality and Safety UK GlycoMar Limited Managing Director UK GSK VP Preclinical Drug Discovery Italy Inovacia AB Head of Research Informatics Sweden IPSEN Pharma, S.A. Head of R&D Informatics Spain JNJ CSO, Head, External Research & Early Development USA Johnson & Johnson Senior Director Belgium Johnson & Johnson Vice President Tox/Path Belgium Kudos Pharmaceuticals Ltd Director, IS/IT UK Lunbeck / HEPTARES  Head of Computational Chemistry, Chief Scientist DK Merck Executive Director IT Discovery / Head of Department BE Merck & Co. Inc.  Executive Director IT Discovery USA Merck Serono . Germany Research Knowledge Management DE Millipore R&D Germany Millipore  Drug Discovery Specialist United Kingdom. MSD Director, Discovery Collaborations UK National Cancer Institute, NIH Program Director, Innovative Molecular Analysis Technologies USA Neurosearch Head of R&D DK Novartis Head Of Text Mining Services  Switzerland Novartis Pharma  LabHead, Development Molecular Pathways Dept. Switzerland Novartis Pharma AG Head BMD Global Office Switzerland Olink Bioscience Director of Sales, Marketing & Support Sweden Olink Bioscience Chief Scientific Officer  Sweden Peakdale Molecular Business Development Director UK Peakdale Molecular Technology Director UK Permedx Consulting Ltd Director, Qualified Kit Development, Meso Scale Discovery UK Pfizer Vice President Research CoE UK Pfizer Senior Director of Pre-competitive Collaborations in Technology USA Pfizer Ri Director  UK Pfizer VP, World Wide Medicinal Chemistry UK Pfizer Senior Principle Scientist UK Pfizer Global Research Vice President for Research, Head of Research Centres of Emphasis  USA Pfizer Inc CSO Neuroscience USA Pfizer UK Associate Director, Therapeutic Area Scientific Informatics Services UK Porsolt SAS CEO / CSO UK Porsolt SAS TBA UK Roche Global Head of Medicinal Chemistry Outsourcing USA Roche / Innovatis Global Sales Director Germany Roche, Basel Head Of Global R&D Basel Sai advantium  Associate Director Business Development, European Region UK Sai advantium  Associate Director  UK Sas European Sales Manager UK SAS Jmp Director of Scientific Discovery and Genomics at SAS USA SAS UK  European Marketing Specialist, JMP UK SCHERING PLOUGH Global Head, R&D Coordination in Molecular Design & Informatics Netherlands Scottish Biomedical Chief Executive UK Scottish Enterprise Manager Life Sciences Scotland Scottish Enterprise. Marketing Director, Life Sciences Scotland Scottish Enterprise. Director, Life Sciences Scotland Sistemic CEO M.D., Ph.D. UK Thermo Fisher Scientific Marketing Director USA ThromboGenics NV Head of Research Belgium Tripos Senior Vice President, Global Sales USA Tripos Senior Director, Product Management USA         Bench-mark and network with up to 120 decision makers & business strategists. Choose from up to forty presentations from some of the world's most renowned speakers. Engage in private meetings with leading suppliers or delegates through our business exchange. Join executive panels & workshops to debate and discuss both strategy and innovation. Create a proposal with your customers in two-way dialogue prior the summit.

Home | Why Attend | Speakers | Programme | Stream Portals | Delegate Package | Sponsorship Packages | Contact Us Delegates | Sponsor & Exhibitors | Media Partners & Press | Venue Accommodation | Book Online | Summit Calender ©2008 All Rights Reserved. GBX Summits Ltd. Company